|
Volumn 15, Issue SUPPL. MAY, 2000, Pages
|
Treatment of chronic liver diseases with traditional Chinese medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIFIBROTIC AGENT;
ANTIINFLAMMATORY AGENT;
ANTIVIRUS AGENT;
BIPHENYL DICARBOXYLATE;
COMPOUND 861;
GIRIFOLA UMBRELLATA POLYSACCHARIDE;
GLUCURONOLACTONE;
GLYCERRHIZIN;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
HEPATITIS B(E) ANTIGEN;
HERBACEOUS AGENT;
IMMUNOMODULATING AGENT;
NEOMINOPHAGEN C;
OXYMATRINE;
PHYLLANTHUS AMARUS EXTRACT;
PHYLLANTHUS NIRURI EXTRACT;
PHYLLANTHUS URINARIA EXTRACT;
RECOMBINANT ALPHA2B INTERFERON;
SCHIZANDRA CHINENSIS BAILL EXTRACT;
UNCLASSIFIED DRUG;
VIRUS DNA;
ANTIBODY TITER;
ANTIINFLAMMATORY ACTIVITY;
ANTIVIRAL ACTIVITY;
CHINA;
CHINESE MEDICINE;
CLINICAL TRIAL;
COLLAGEN DEGRADATION;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG MECHANISM;
ENZYME INHIBITION;
FIBROGENESIS;
FRUIT;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOMODULATION;
LIVER CIRRHOSIS;
LIVER PROTECTION;
NONHUMAN;
PLANT ROOT;
PRIORITY JOURNAL;
SEROCONVERSION;
TREATMENT OUTCOME;
|
EID: 0033944607
PISSN: 08159319
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1746.2000.02100.x Document Type: Conference Paper |
Times cited : (126)
|
References (11)
|